Allarity Therapeutics Ratios (2024-2025) | ALLR

Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
EBT Margin (Quarter) 3,771.57%382.39%23,934.00%-11,897.33%4,736.84%19,333.33%4,922.81%-3,891.53%
EBIT Margin (Quarter) 4,156.86%791.31%24,626.00%-19,594.67%5,326.32%34,441.67%4,417.54%4,945.76%
EBITDA Margin (Quarter) 3,743.14%416.20%23,506.00%9,485.33%5,277.19%34,583.33%4,645.61%3,544.07%
Operating Margin (Quarter) 4,156.86%791.31%24,626.00%-19,594.67%5,326.32%34,441.67%4,417.54%4,945.76%
Net Margin (Quarter) 3,803.92%391.78%24,304.00%9,937.33%4,792.98%19,333.33%4,922.81%5,716.95%
FCF Margin (Quarter) 1,371.57%1,714.55%10,886.00%4,274.67%4,712.28%45,675.00%5,982.46%5,496.61%
Efficiency
Assets Average (Quarter) 21.43M25.63M21.51M26.19M25.47M21.00M19.53M
Equity Average (Quarter) 6.68M16.40M12.39M15.24M15.42M12.09M10.92M
Invested Capital (Quarter) -3.81M19.85M12.97M11.81M18.67M12.17M12.01M9.83M
Asset Utilization Ratio (Quarter) -0.03-0.02-0.01-0.01-0.01
Leverage & Solvency
Interest Coverage Ratio (Quarter) -41.57-7.91-246.26195.95-53.26-344.42-44.18-49.46
Debt to Equity (Quarter) -0.410.000.000.00
Debt Ratio (Quarter) 0.220.000.000.00
Equity Ratio (Quarter) -0.540.640.640.520.630.570.580.54
Times Interest Earned (Quarter) -41.57-7.91-246.26195.95-53.26-344.42-44.18-49.46
Valuation
Enterprise Value (Quarter) -0.31M-19.23M-18.46M-0.07M-2.50M-14.77M
Return Ratios
Return on Sales (Quarter) 37.68%3.82%231.80%-118.97%47.37%193.33%49.23%-38.92%
Return on Capital Employed (Quarter) -0.49%-0.27%-0.29%0.41%-1.14%
Return on Invested Capital (Quarter) -0.40%-0.25%-0.30%
Return on Assets (Quarter) -0.38%-0.27%-0.30%0.05%-0.28%
Return on Equity (Quarter) -0.66%-0.46%-0.50%0.09%-0.51%